Interestingly, these data align closely with data for other GEFs such as GIT1 which when silenced via siRNA (or indeed miR-149) was shown to decrease invasion and metastases in the setting of triple negative breast cancer [50]. This evidence concerns the gene GIT1 and triple-negative breast carcinoma.